Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Two Massachusetts biotechs that are now valued lower than their bank accounts
Two Massachusetts biotechs that are now valued lower than their bank accounts
Two Massachusetts biotechs that are now valued lower than their bank accounts
Submitted by
admin
on February 12, 2016 - 9:37am
Source:
Bizjournals.com
News Tags:
Synta Pharmaceuticals
Eleven Biotherapeutics
Headline:
Two Massachusetts biotechs that are now valued lower than their bank accounts
Do Not Allow Advertisers to Use My Personal information
